Small Molecule Drug Discovery Market Trends Report 2025 – For Business Development and Strategy Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#What Is the Forecast for the Small Molecule Drug Discovery Market Growth in 2025?#_x000D_
The market for small molecule drug discovery has seen vigorous growth in the past few years. It is estimated to expand from $62.44 billion in 2024 to $68.57 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. The significant growth during the historic period is due to factors such as initiatives for drug repurposing, automation in the process of drug discovery, heightened investment in research and development, regulatory backing for drug development, and advancements in high-throughput screening._x000D_
_x000D_
#What Is the Forecast for the Small Molecule Drug Discovery Market Size Through 2029?#_x000D_
The market size for small molecule drug discovery is anticipated to expand quickly in the coming years. The projected growth will see the market valued at $106.91 billion in 2029, with a compound annual growth rate (CAGR) of 11.7%. This anticipated growth for the forecast period is largely attributed to the introduction of unique therapeutic targets, a shift towards patient-centric drug discovery, the development of drug-device combination products, the use of real-world evidence, the integration of pharmacogenomics, and global health obstacles. Key trends in the forecast period include the advent of fragment-based drug discovery, the use of artificial intelligence in drug discovery, RNA-targeted therapeutics, collaborations and partnerships, innovative drug delivery methods, and the use of organoids and 3D cell culture models._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp_x000D_
_x000D_
#What are the Key Market Players in Small Molecule Drug Discovery Market and How They’re Evolving?#_x000D_
Major companies operating in the small molecule drug discovery market include Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Clinuvel Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Pharmacosmos, Allarity Therapeutics, Xellia Pharmaceuticals, Cyteir Therapeutics, BigHat Biosciences_x000D_
_x000D_
#What Are the Primary Growth Drivers in the Small Molecule Drug Discovery Market?#_x000D_
The small molecule drug discovery market is anticipated to grow due to the increasing prevalence of chronic diseases. Chronic diseases are conditions lasting a year or more that disrupt daily life and require continual medical attention. Small-molecule drugs treat chronic illnesses such as HIV, cancer, infections, heart disease, and kidney disease and are generally more affordable for patients with chronic ailments. Therefore, the rising prevalence of chronic diseases is set to propel the small molecule drug discovery market. For instance, a study by the National Institutes of Health (NIH), an American biomedical research agency, predicted that in 2023 the number of Americans aged 50 and older with at least one chronic ailment would inflate by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Furthermore, the population with multimorbidity is expected to surge by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Consequently, the escalating prevalence of chronic diseases underpins the growth of the small molecule drug discovery market._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=9834&type=smp_x000D_
_x000D_
#What Are the Leading Segments in the Global Small Molecule Drug Discovery Industry?#_x000D_
The small molecule drug discovery market covered in this report is segmented –_x000D_
_x000D_
1) By Drug Type: Small Molecule Drugs, Biologic Drugs_x000D_
2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others_x000D_
3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others_x000D_
4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization_x000D_
5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others_x000D_
_x000D_
Subsegments:_x000D_
1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs_x000D_
2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies_x000D_
_x000D_
#What Are the Key Market Trends in the Small Molecule Drug Discovery Industry?#_x000D_
The primary trend currently popular in the small molecule drug discovery market is technological innovation. Key companies in this market are prioritizing the development of novel products. For example, Dotmatics, an American digital science platform provider, debuted its Small Molecule Drug Discovery Solution in January 2023. This solution, which features pre-configured workflows and enhanced data administration capabilities, is innovatively designed within an integrated scientific R&D framework. The outcome is a reduction in operational inefficiencies and an acceleration of the process from data insight to decision-making._x000D_
_x000D_
#Access The Full Report Here:#_x000D_
_x000D_
#What Is the Regional Outlook for the Small Molecule Drug Discovery Market?#_x000D_
North America was the largest region in the small molecule drug discovery market in 2024. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
#Purchase The Full Report Today:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9834_x000D_
_x000D_
#This Report Delivers Insight On: #_x000D_
1. How big is the small molecule drug discovery market, and how is it changing globally?_x000D_
2. Who are the major companies in the small molecule drug discovery market, and how are they performing?_x000D_
3. What are the key opportunities and risks in the small molecule drug discovery market right now?_x000D_
4. Which products or customer segments are growing the most in the small molecule drug discovery market?_x000D_
5. What factors are helping or slowing down the growth of the small molecule drug discovery market?_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 3156230293_x000D_
Asia +44 2071930708_x000D_
Europe +44 2071930708_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
